A Single Arm Phase II Study of Palbociclib in Combinatio

Project: Research project

Description

A Single Arm Phase II Study of Palbociclib in Combination with Tamoxifen as First Line Therapy for Metastatic Hormone Receptor Positive Breast Cancer
StatusActive
Effective start/end date6/1/165/31/22

Funding

  • HOOSIER CANCER RESEARCH NETWORK, INC.

Fingerprint

Tamoxifen
Hormones
Breast Neoplasms
Therapeutics
palbociclib